Drug Diary

BEHAVIORAL3 trials

Sponsors

Children's Hospital Medical Center, Cincinnati, Wake Forest University Health Sciences

Conditions

Invasive Breast CancerKidney TransplantTriple Negative Breast CancerVitamin D Deficiency

Phase 1

Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients

TerminatedNCT00433953

Children's Hospital Medical Center, CincinnatiKidney Transplant

Start: 2007-02-28End: 2010-02-28Updated: 2013-02-20

Phase 2

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

RecruitingNCT04677816

Wake Forest University Health SciencesInvasive Breast Cancer, Triple Negative Breast Cancer, Vitamin D Deficiency

Start: 2021-10-22End: 2026-12-01Target: 50Updated: 2026-08-28

Unknown Phase

PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients

CompletedNCT00281619

Children's Hospital Medical Center, CincinnatiKidney Transplant

Start: 2006-01-31End: 2010-02-28Updated: 2013-12-19